IMTHELIS Trademark

Trademark Overview

On Thursday, April 20, 2017, a trademark application was filed for IMTHELIS with the United States Patent and Trademark Office. The USPTO has given the IMTHELIS trademark a serial number of 87418630. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2020. This trademark is owned by GENENTECH, INC.. The IMTHELIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neuromyelitis optica spectrum disorder
imthelis

General Information

Serial Number87418630
Word MarkIMTHELIS
Filing DateThursday, April 20, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neuromyelitis optica spectrum disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Trademark Events

Event DateEvent Description
Monday, November 16, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 16, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 23, 2020EXTENSION 5 GRANTED
Monday, March 16, 2020EXTENSION 5 FILED
Monday, March 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 16, 2020TEAS EXTENSION RECEIVED
Tuesday, September 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2019EXTENSION 4 GRANTED
Friday, September 13, 2019EXTENSION 4 FILED
Friday, September 13, 2019TEAS EXTENSION RECEIVED
Friday, March 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2019EXTENSION 3 GRANTED
Wednesday, February 27, 2019EXTENSION 3 FILED
Wednesday, February 27, 2019TEAS EXTENSION RECEIVED
Wednesday, September 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 17, 2018EXTENSION 2 GRANTED
Monday, September 17, 2018EXTENSION 2 FILED
Monday, September 17, 2018TEAS EXTENSION RECEIVED
Thursday, April 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 3, 2018EXTENSION 1 GRANTED
Tuesday, April 3, 2018EXTENSION 1 FILED
Tuesday, April 3, 2018TEAS EXTENSION RECEIVED
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2017ASSIGNED TO EXAMINER
Wednesday, April 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 24, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

imthelis spectrum disorder optica neuromyelitis preparations treatment pharmaceutical